BIOTECHNOLOGY VALUE FUND L P - 05 Aug 2025 SCHEDULE 13D/A Report for ESSA Pharma Inc. Common Shares (EPIX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
ESSA Pharma Inc. Common Shares
Symbol
EPIX
Shares outstanding
47,240,781 shares
Disclosed Ownership
11,668,473 shares
Ownership
25%
Form type
SCHEDULE 13D/A
Filing time
07 Aug 2025, 16:31:00 UTC
Date of event
05 Aug 2025
Previous filing
09 Apr 2025
Next filing
14 Oct 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 13% 6,194,145 0 6,194,145 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0000918923
BVF I GP LLC 13% 6,194,145 0 6,194,145 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803805
BIOTECHNOLOGY VALUE FUND II LP 10% 4,726,743 0 4,726,743 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001102444
BVF II GP LLC 10% 4,726,743 0 4,726,743 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803806
Biotechnology Value Trading Fund OS LP 1.2% 560,797 0 560,797 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660683
BVF Partners OS Ltd. 1.2% 560,797 0 560,797 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660684
BVF GP HOLDINGS LLC 23% 10,920,888 0 10,920,888 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803809
BVF PARTNERS L P/IL 25% 11,668,473 0 11,668,473 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001055947
BVF INC/IL 25% 11,668,473 0 11,668,473 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001056807
LAMPERT MARK N 25% 11,668,473 0 11,668,473 /s/ Mark N. Lampert Mark N. Lampert 0001233840